News Conference News TCT 2020 While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry L.A. McKeown October 21, 2020
News Conference News TCT 2020 Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT Todd Neale October 21, 2020
News Conference News TCT 2020 Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results Todd Neale October 15, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News TCT 2020 STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI Caitlin E. Cox October 14, 2020
News Conference News TCT 2020 OCT Proves Predictive in Diabetic Patients, Even in FFR-Negative Lesions Shelley Wood October 14, 2020
Presentation TCT 2020 TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial. Presenter: Elvin Kedhi October 14, 2020
Presentation TCT 2020 TCT 304: Meta-Analysis of Long-term Outcomes in Patients With Diabetes Mellitus and Left Main Coronary Artery Disease Treated With Drug-eluting Stent Versus Coronary Artery Bypass Grafting Presenter: Abdullah Al-abcha October 14, 2020
Presentation TCT 2020 TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR) Presenter: Jason Nogic October 14, 2020
Presentation TCT 2020 TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry Presenter: Adrian Wlodarczak October 14, 2020
News Daily News TCT 2019 BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On L.A. McKeown October 02, 2019
News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
Presentation TCT 2019 BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI Presenter: Philippe Genereux September 29, 2019
Presentation TCT 2019 The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population Presenter: Antonio Colombo September 28, 2019
Presentation TCT 2019 The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience) Presenter: Azeem Latib September 28, 2019
Presentation TCT 2019 Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept Presenter: Roxana Mehran September 28, 2019
Presentation TCT 2019 LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease Presenter: Marianne Brodmann September 27, 2019